Parkinson's Disease Trial, Recruiting NCT06804642 Sponsor: University of Louisville Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06804642
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease
  • You are between 18 and 80 years old
  • You are able to understand and agree to take part in the research on your own
  • You are able to understand and follow instructions given during the study
  • You are able to walk at least 10 metres (about 33 feet)

Who may not be able to join:

  • You have another condition (besides Parkinson's) that significantly affects the way you walk
  • You have significant memory or thinking problems
  • You have significant depression, schizophrenia, bipolar disorder, or another serious active mental health condition
  • You have a terminal illness where doctors expect you may have less than 12 months to live
  • You have been diagnosed with serious heart failure or a major heart condition, as decided by the study doctors
  • You currently have an alcohol or drug misuse problem that is not being managed or controlled
  • You are not able to communicate with the research team
  • You have any other illness that, in the study doctors' opinion, would prevent you from safely taking part in the treatments or assessments involved in this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Ovechkin, MD, Ph.D., University of Louisville

Phone: 5025874871

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Louisville
Registry
ClinicalTrials.gov
Start date
12 December 2024
Est. completion
11 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

A. Assessment of Multisegmental Motor Responses (MMR); Spinal Cord Transcutaneous Stimulation (scTS) Mapping electromyography (EMG); Spinal Cord Transcutaneous Stimulation (scTS) Mapping electroencephalography (EEG); Stepping Performance in a Gravity-Neutral Device (GND) with electromyography (EMG).; Stepping Performance in a Gravity-Neutral Device (GND) with kinematics.; Stepping Performance in a Gravity-Neutral Device (GND) with plantar stimulation.; Stepping Performance in a Gravity-Neutral Device (GND) with electroencephalography (EEG).; D. Assessment of Balance and Gait: Tinetti Balance &...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov